Effectiveness of inactivated and Ad5-nCoV COVID-19 vaccines against SARS-CoV-2 Omicron BA. 2 variant infection, severe illness, and death

被引：0
作者：
Zhuoying Huang
Shuangfei Xu
Jiechen Liu
Linlin Wu
Jing Qiu
Nan Wang
Jia Ren
Zhi Li
Xiang Guo
Fangfang Tao
Jian Chen
Donglei Lu
Xiaodong Sun
Weibing Wang
机构：
[1] Institute of Immunization,Shanghai Institute of Infectious Disease and Biosecurity, School of Public Health
[2] Shanghai Municipal Center of Disease Control and Prevention,Division of Health Risk Factors Monitoring and Control
[3] Fudan University,Key Laboratory of Public Health Safety of Ministry of Education
[4] Institute of Infectious Diseases,undefined
[5] Shanghai Municipal Center of Disease Control and Prevention,undefined
[6] Shanghai Municipal Center of Disease Control and Prevention,undefined
[7] Fudan University,undefined
来源：
BMC Medicine | / 20卷
关键词：
COVID-19; Vaccine effectiveness; Case-control study; Inactivated vaccine;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 71 条
  • [1] Viana R(2022)Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in southern Africa Nature 603 679-686
  • [2] Moyo S(2022)Characterization and antiviral susceptibility of SARS-CoV-2 Omicron/BA. 2 Nature 607 119-127
  • [3] Amoako DG(2022)Neutralization of the SARS-CoV-2 Omicron BA. 1 and BA. 2 variants N Engl J Med 386 1579-1580
  • [4] Uraki R(2021)BNT162b2 mRNA COVID-19 vaccine in a nationwide mass vaccination setting N Engl J Med 384 1412-1423
  • [5] Kiso M(2021)Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data Lancet 397 1819-1829
  • [6] Iida S(2021)FDA-authorized mRNA COVID-19 vaccines are effective per real-world evidence synthesized across a multi-state health system Med (N Y) 2 979-92 e8
  • [7] Yu J(2022)COVID-19 vaccine effectiveness against the Omicron (B.1.1.529) variant N Engl J Med 386 1532-1546
  • [8] Collier AY(2021)mRNA-1273 COVID-19 vaccine effectiveness against the B.1.1.7 and B.1.351 variants and severe COVID-19 disease in Qatar Nat Med 27 1614-1621
  • [9] Rowe M(2022)Comparative vaccine effectiveness against severe COVID-19 over time in US hospital administrative data: a case-control study Lancet Respir Med 10 557-565
  • [10] Dagan N(2022)Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies Nature 602 657-663
12345678